speb/financial-data huggingface dataset:
CHR.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1055800000.00
CHR.DE income_statement (annual, 2025-12-31) — Total Expenses: 2189500000.00
CHR.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 540700000.00
CHR.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6428700000.00
CHR.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6428700000.00
CHR.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7041300000.00
CHR.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7041300000.00
CHR.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5695400000.00
CHR.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5695400000.00
CHR.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 683800000.00
CHR.DE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 123500000.00
CHR.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -52600000.00
CHR.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1700000.00
CHR.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -52600000.00
CHR.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1700000.00
CHR.DE balance_sheet (annual, 2025-12-31) — Working Capital: -290100000.00
CHR.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: -290100000.00
CHR.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 59000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 663000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 218000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 33000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 70000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 1.16
CHR.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 289000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -59000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -59000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 8000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 200000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 200000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -31000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -232000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -61000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 295000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 128000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 128000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1096000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
CHR.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 460000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 196000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 452000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 8000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Debt: 63000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 71000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 158000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 158000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 836000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 19000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 19000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 58000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 58000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 58000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 70000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.16
CHR.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 81000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 36000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 0.00
CHR.DE income_statement (quarterly, 2026-03-31) — EBIT: 185000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — EBITDA: 243000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 36000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -36000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 291000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -232000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 236000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 900000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 3416000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 203000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CHR.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 72000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 72000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 43000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 76000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 11000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6024000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -61000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 685000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 245000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4865000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4865000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 245000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -449000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 685000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 48000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 4728000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income: 83000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 81000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 83000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 83000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 83000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 83000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 83000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -72000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -198000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -204000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -72000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -3000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -2000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 2910000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 6000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2320000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 554000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 15000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 539000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 244000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 83733000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 295000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -36000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Operating Income: 144000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 663000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 69696376.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 63000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 147000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: 41000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2516000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 22000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 86000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Payable: 46000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 71000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 2000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Payables: 264000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 460000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 42000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 113000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 105000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -5000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 460000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 58000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -449000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 91000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 1000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1094000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 59000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 69696376.00
CHR.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -1000000.00
CHR.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 5000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1096000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2320000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -267000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 30000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
CHR.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 6000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 7485000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5961000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 4936000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1144000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 519000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6341000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7033000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5505000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 143000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1000000.00
CHR.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1000000.00
CHR.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: -384000000.00
CHR.TO cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -1309000.00
CHR.TO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 68560000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 10708000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 0.00
CHR.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 7218000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Financial Assets: 0.00
CHR.TO balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 0.00
CHR.TO balance_sheet (annual, 2021-12-31) — Investments And Advances: 0.00
CHR.TO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 68560000.00
CHR.TO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 175834000.00
CHR.TO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 175834000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Long Term Provisions: 100042000.00
CHR.TO cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
CHR.TO balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 6661000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 6661000.00
CHR.TO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 344000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 911000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Properties: 0.00
CHR.TO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 10090000.00
CHR.TO cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
CHR.TO balance_sheet (annual, 2021-12-31) — Raw Materials: 76235000.00
CHR.TO balance_sheet (annual, 2021-12-31) — Restricted Cash: 54873000.00
CHR.TO cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
CHR.TO cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CHR.TO income_statement (annual, 2022-12-31) — +Operating Expense: 235131000.00
CHR.TO income_statement (annual, 2022-12-31) — +Total Revenue: 1595804000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 312810000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 185630000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1023921000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1037801000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1614000.00
CHR.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 27777227.00
CHR.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.91
CHR.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 178446000.00
CHR.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -62280000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 11309000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 788698000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 100027000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 100027000.00
CHR.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -14616000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 100027000.00
CHR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -71459000.00
CHR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -231369000.00
CHR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 279512000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 63717000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 26641000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -19505000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 16054000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -8136000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 1909000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Payable: 90358000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 90358000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -6214000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -45693000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Tax Payable: 26641000.00
CHR.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 28773000.00
CHR.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -44622000.00
CHR.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -23316000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Common Stock: 788698000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1179573000.00
CHR.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 465038000.00
CHR.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -5463000.00
CHR.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 1172407000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Assets: 503748000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5041000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Debt: 340308000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 345349000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 8888000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 8888000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 732689000.00
CHR.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -14245000.00
CHR.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -14245000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 16781000.00
CHR.TO cash_flow (annual, 2022-12-31) — Depreciation: 202613000.00
CHR.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 202613000.00
CHR.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 202613000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 3813000.00
CHR.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 28435308.00
CHR.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.91
CHR.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 25988000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Dividends Payable: 8888000.00
CHR.TO income_statement (annual, 2022-12-31) — EBIT: 178740000.00
CHR.TO income_statement (annual, 2022-12-31) — EBITDA: 381353000.00
CHR.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 12781000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 32973000.00
CHR.TO cash_flow (annual, 2022-12-31) — End Cash Position: 167911000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Financial Assets: 6065000.00
CHR.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -71459000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 0.00
CHR.TO balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: 28437000.00
CHR.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 217232000.00
CHR.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -3185000.00
CHR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 172000.00
CHR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -13745000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 28437000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Goodwill: 9010000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 27890000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 187244000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 4305929000.00
CHR.TO income_statement (annual, 2022-12-31) — Gross Profit: 423397000.00
CHR.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 10518000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 29335000.00
CHR.TO income_statement (annual, 2022-12-31) — Interest Expense: 104890000.00
CHR.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 104890000.00
CHR.TO income_statement (annual, 2022-12-31) — Interest Income: 4047000.00
CHR.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4047000.00
CHR.TO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 102493000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Inventory: 113820000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 3198540000.00
CHR.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -231369000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 26008000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 26008000.00
CHR.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 465038000.00
CHR.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CHR.TO balance_sheet (annual, 2022-12-31) — Leases: 14405000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 6268000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 1678659000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1684927000.00
CHR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CHR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -509985000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 136509000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 47317000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 88850000.00
CHR.TO income_statement (annual, 2022-12-31) — Minority Interests: -3027000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -464831000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 459575000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Net Debt: 1918940000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 14040000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income: 48890000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 25988000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 51917000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 48890000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 48890000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 51917000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 51917000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Interest Income: -100843000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -5816000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -509985000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -509985000.00
CHR.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -100843000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -6433000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 30251000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Net PPE: 3282008000.00
CHR.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 209027000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1151683000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 42797000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 22240000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 187684000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 22240000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 187684000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
CHR.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 394926000.00
CHR.TO income_statement (annual, 2022-12-31) — Normalized Income: 58431819.00
CHR.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 279512000.00
CHR.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 10855000.00
CHR.TO income_statement (annual, 2022-12-31) — Operating Income: 188266000.00
CHR.TO income_statement (annual, 2022-12-31) — Operating Revenue: 1595804000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 28761716.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 340308000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 27049000.00
CHR.TO income_statement (annual, 2022-12-31) — Other Income Expense: -13573000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 18880000.00
CHR.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -534000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 151218000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 145400000.00
CHR.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 219345000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Payable: 18156000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Properties: 97587000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 7737000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Payables: 384519000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 384519000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2821000.00
CHR.TO cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -14616000.00
CHR.TO income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 22902000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 18213000.00
CHR.TO income_statement (annual, 2022-12-31) — Pretax Income: 73850000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CHR.TO income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 15786000.00
CHR.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
CHR.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -464831000.00
CHR.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5816000.00
CHR.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -62280000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 113820000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Receivables: 203804000.00
CHR.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1172407000.00
CHR.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 202613000.00
CHR.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -509985000.00
CHR.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -5463000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Restricted Cash: 67884000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -702412000.00
CHR.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 2399000.00
CHR.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 271307000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Share Issued: 28761716.00
CHR.TO income_statement (annual, 2022-12-31) — Special Income Charges: 172000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1179573000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1151683000.00
CHR.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -4031181.00
CHR.TO income_statement (annual, 2022-12-31) — Tax Provision: 21933000.00
CHR.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.30
CHR.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 10437000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Assets: 4055909000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 2858232000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Debt: 2030276000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1268423000.00
CHR.TO income_statement (annual, 2022-12-31) — Total Expenses: 1407538000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2787486000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3552161000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2054797000.00
CHR.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 188266000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 44665000.00
CHR.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -13573000.00
CHR.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -13573000.00
CHR.TO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 133000.00
CHR.TO balance_sheet (annual, 2022-12-31) — Working Capital: -228941000.00
CHR.TO income_statement (annual, 2023-12-31) — +Operating Expense: 178597000.00
CHR.TO income_statement (annual, 2023-12-31) — +Total Revenue: 1399611000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 298060000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 208066000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1221559000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1034194000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -6638000.00
CHR.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 27905446.00
CHR.TO income_statement (annual, 2023-12-31) — Basic EPS: 2.36
CHR.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 167911000.00
CHR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -42287000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 10576000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 781698000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 85985000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 85985000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -35124000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 85985000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -154224000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -39360000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 158013000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: -171326000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 76917000.00
CHR.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: 141662000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -3634000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -2140000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -5662000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -21451000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1816000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 56000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Payable: -5774000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -5774000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1679000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -8729000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Tax Payable: -2140000.00
CHR.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -38065000.00
CHR.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -8660000.00
CHR.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 11682000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Common Stock: 781698000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1193884000.00
CHR.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -25536000.00
CHR.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 1062484000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 0.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Assets: 630811000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3309000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Debt: 430082000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 433391000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 804773000.00
CHR.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 17563000.00
CHR.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 17563000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 6496000.00
CHR.TO cash_flow (annual, 2023-12-31) — Depreciation: 91479000.00
CHR.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 91479000.00
CHR.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 91479000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 4391000.00
CHR.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 28748422.00
CHR.TO income_statement (annual, 2023-12-31) — Diluted EPS: 2.29
CHR.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 65927000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Dividends Payable: 8680000.00
CHR.TO income_statement (annual, 2023-12-31) — EBIT: 179880000.00
CHR.TO income_statement (annual, 2023-12-31) — EBITDA: 271359000.00
CHR.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -3176000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Employee Benefits: 39324000.00
CHR.TO cash_flow (annual, 2023-12-31) — End Cash Position: 176417000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Financial Assets: 1967000.00
CHR.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -325550000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 86743000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: 325000.00
CHR.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 257388000.00
CHR.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -13000.00
CHR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 13000.00
CHR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 19154000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 325000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Goodwill: 8966000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 23566000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 214704000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 4188122000.00
CHR.TO income_statement (annual, 2023-12-31) — Gross Profit: 337127000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 38795000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 10915000.00
CHR.TO income_statement (annual, 2023-12-31) — Interest Expense: 42836000.00
CHR.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 42836000.00
CHR.TO income_statement (annual, 2023-12-31) — Interest Income: 2183000.00
CHR.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2183000.00
CHR.TO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 99645000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Inventory: 206533000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 2938888000.00
CHR.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 37557000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 24823000.00
CHR.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 86984000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Leases: 14376000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 7267000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 1314922000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1322189000.00
CHR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 86984000.00
CHR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -180548000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 184136000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 47953000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 86585000.00
CHR.TO income_statement (annual, 2023-12-31) — Minority Interests: -4753000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -25536000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Net Debt: 1659019000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -14707000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income: 101353000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 65927000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 101630000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 4476000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 101353000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 96877000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 101630000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 106106000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Interest Income: -40653000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1613000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -93564000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -93564000.00
CHR.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -40653000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -4979000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 2914000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Net PPE: 2966563000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -42274000.00
CHR.TO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
CHR.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1170318000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 168550000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 18286000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 212919000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 18286000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 212919000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1653000.00
CHR.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 252192000.00
CHR.TO income_statement (annual, 2023-12-31) — Normalized Income: 82655086.00
CHR.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 299675000.00
CHR.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -14720000.00
CHR.TO income_statement (annual, 2023-12-31) — Operating Income: 158530000.00
CHR.TO income_statement (annual, 2023-12-31) — Operating Revenue: 1399611000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 27632505.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 430082000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2311000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 27049000.00
CHR.TO income_statement (annual, 2023-12-31) — Other Income Expense: 19167000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 14600000.00
CHR.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 126000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 9805000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 186802000.00
CHR.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 177682000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Payable: 24151000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Properties: 107126000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 12280000.00
CHR.TO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CHR.TO balance_sheet (annual, 2023-12-31) — Payables: 366194000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 366194000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2877000.00
CHR.TO cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -35124000.00
CHR.TO income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 35426000.00
CHR.TO cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
CHR.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 16515000.00
CHR.TO income_statement (annual, 2023-12-31) — Pretax Income: 137044000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
CHR.TO income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 915000.00
CHR.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1613000.00
CHR.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -42287000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 119790000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Receivables: 231346000.00
CHR.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1062484000.00
CHR.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 91479000.00
CHR.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -180548000.00
CHR.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -25536000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Restricted Cash: 90432000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -649382000.00
CHR.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 5896000.00
CHR.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 13000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Share Issued: 27632505.00
CHR.TO income_statement (annual, 2023-12-31) — Special Income Charges: 13000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1193884000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1170318000.00
CHR.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 4945086.00
CHR.TO income_statement (annual, 2023-12-31) — Tax Provision: 35414000.00
CHR.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
CHR.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 11000000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Assets: 3850867000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 2508806000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Debt: 1755580000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1280469000.00
CHR.TO income_statement (annual, 2023-12-31) — Total Expenses: 1241081000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2570398000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3220056000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1765625000.00
CHR.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 158530000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 35303000.00
CHR.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 19167000.00
CHR.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 19167000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CHR.TO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -3555000.00
CHR.TO balance_sheet (annual, 2023-12-31) — Working Capital: -173962000.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 2092615000.00
CHR.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 27301265.00
CHR.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.72
CHR.TO cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Financing Activities: -53184000.00
CHR.TO cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Investing Activities: 41628000.00
CHR.TO cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Operating Activities: 24918000.00
CHR.TO cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 10325000.00
CHR.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 28355843.00
CHR.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.70
CHR.TO balance_sheet (quarterly, 2024-09-30) — Dividends Payable: 0.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 687000.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Minority Interest: 88912000.00
CHR.TO income_statement (quarterly, 2024-09-30) — Minority Interests: 1352000.00
CHR.TO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: -1392000.00
CHR.TO cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 0.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 0.00
CHR.TO balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1664895000.00